Your session is about to expire
← Back to Search
Weight Loss App for Obesity
N/A
Recruiting
Led By Marya Schulte, PhD
Research Sponsored by University of California, Los Angeles
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 5 months
Awards & highlights
No Placebo-Only Group
Summary
This trial aims to develop an app to help with weight loss for obese adolescents, based on displacement theory to help with addictive behaviors.
Who is the study for?
This trial is for adolescents aged 14-18 with obesity (BMI ≥95th percentile) who are motivated to lose weight, can read and speak English, and have access to an iPhone. They should not be on weight-altering medications or have certain medical conditions like Prader-Willi Syndrome. Those already in another weight loss program or with psychiatric conditions that could interfere with the study cannot join.
What is being tested?
The BrainWeighve app, based on displacement theory, is being tested as a tool for managing obesity in teenagers. The study involves beta testing by groups of teens followed by a four-month trial period where engagement, satisfaction, and the app's impact on clinical outcomes such as weight/BMI and food-related addictive behaviors will be evaluated.
What are the potential side effects?
Since this intervention involves using an app rather than medication or invasive procedures, traditional side effects are not expected. However, participants may experience frustration or lack of interest if they do not find the app engaging.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 5 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~5 months
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Quality of Engagement with App
Quantity of Engagement with App
Satisfaction with the App as assessed by the Treatment Satisfaction Questionnaire
Secondary study objectives
%BMI95
Automated Self-Administered 24-Hour Dietary Assessment Tool
Distress Tolerance Scale
+7 moreOther study objectives
Reach and Retention Rates
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: BrainWeighve InterventionExperimental Treatment1 Intervention
4-month smartphone-based weight loss intervention for teens based on displacement theory of addictive behaviors
Find a Location
Who is running the clinical trial?
eHealth International, INC.UNKNOWN
1 Previous Clinical Trials
20 Total Patients Enrolled
1 Trials studying Weight Loss
20 Patients Enrolled for Weight Loss
Children's Hospital Los AngelesOTHER
248 Previous Clinical Trials
5,074,578 Total Patients Enrolled
2 Trials studying Weight Loss
361 Patients Enrolled for Weight Loss
University of California, Los AngelesLead Sponsor
1,565 Previous Clinical Trials
10,263,143 Total Patients Enrolled
9 Trials studying Weight Loss
547 Patients Enrolled for Weight Loss
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am between 14 and 18 years old.I plan to start losing weight within the next month.I have been diagnosed with a condition linked to obesity, such as Prader-Willi Syndrome.I am not taking medications that significantly change my weight.I am motivated to change based on a specific questionnaire.My BMI is in the top 5% for my age and gender.You have been trying to lose weight or stay at a healthy weight for more than 6 months by eating a healthy diet and exercising.You have answered questions on a survey and scored 17 or higher in the section about your goals and attitudes towards a weight management program.You have tried to lose weight by dieting or exercising, but you have only been doing it for less than 6 months.
Research Study Groups:
This trial has the following groups:- Group 1: BrainWeighve Intervention
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Other Trials to Consider
Popular Categories
Learn More About These Treatments
Share this study with friends
Copy Link
Messenger